FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

3 FDA Innovative Manufacturing Action Steps

FDA issues a strategy document on innovative manufacturing technologies with three action steps it will take.

latest-news-card-1
Medical Devices

FDA Warns 2 Chinese Labs About Data Concerns

FDA says it sent Warning Letters to two Chinese nonclinical labs airing concerns about data integrity.

latest-news-card-1
Human Drugs

Lawsuit Against FDA Dismissed on Ripeness Grounds

The Washington, DC District Court dismisses a Vanda Pharmaceuticals lawsuit against FDA that challenged the agencys bioequivalence determination of a ...

latest-news-card-1
Human Drugs

Ocaliva Confirmatory Trial Fails: FDA

FDA asks members of its Gastrointestinal Drugs Advisory Committee whether they believe that the benefits of using Intercepts Ocaliva to treat some cas...

latest-news-card-1
Biologics

GSK Nixes Herpes Simplex Virus Vaccine

GSK decides to not advance the development of an investigational herpes simplex virus vaccine candidate based on data from a recent Phase 1-2 study.

Medical Devices

Hinge Health Wireless Pain Device Cleared

FDA clears a Hinge Health 510(k) for its Enso 3, a wireless device for reducing musculoskeletal pain.

latest-news-card-1
Human Drugs

CDER Quantitative Medicine CoE Explained

CDER Quantitative Medicine Center of Excellence lead Rajanikanth Madabushi explains the new units role in drug development and regulatory review.

latest-news-card-1
Human Drugs

CGMP Violations at Zydus Lifesciences Facility

FDA warns Zydus Lifesciences Limited about CGMP violations in its production of finished drugs.

latest-news-card-1
Medical Devices

Multiple Optikem International Violations Cited

FDA warns Denver, CO-based Optikem International about Quality System Regulation and other violations in its production of ophthalmic solutions.

latest-news-card-1

Changes Sought in FDA Misinformation Guidance

Three trade groups representing companies regulated by FDA recommend changes to a draft guidance on addressing misinformation about prescription drugs...